Alnylam Gets Orphan Drug Status for Potential Treatment for Rare

Alnylam gets orphan drug status for potential treatment for rare

Filed under: Drug Rehab Centers Washington D.C.

Alnylam Pharmaceuticals Inc. said Tuesday that it received special regulatory incentives for a drug designed to treat a potentially fatal neurodegenerative …
Read more on Greenfield Daily Reporter


Collaboration Between Sanofi And Joslin Diabetes Center To Focus

Filed under: Drug Rehab Centers Washington D.C.

… promote the development of new medicines for the treatment of diabetes and related … Joslin Diabetes Center is the world's leading diabetes research and clinical care … whether and when to approve any drug, device or biological application that …
Read more on Daily Markets (press release)


I-SPY 2 Trial Results in Proposed Accelerated FDA Approval Path

Filed under: Drug Rehab Centers Washington D.C.

(Washington, D.C.) I-SPY 2 (Investigation of Serial Studies to Predict Your … new drugs in high risk breast cancers in the neoadjuvant (drug treatment prior to … Buck Breast Care Center at the University of California, San Francisco Helen Diller …
Read more on NCTechNews (press release)


Leave a Reply

Your email address will not be published. Required fields are marked *